Semi-synthetic strategies to obtain glucosylated MOG to identify antibodies as biomarkers in multiple sclerosis disease.
Gori
Francesca
F
Department of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino, FL, Italy.
Mulinacci
Barbara
B
Bonchi
Eva
E
Chelli
Mario
M
Lolli
Francesco
F
Papini
Anna M
AM
Rovero
Paolo
P
D000906:Antibodies / Q000276:immunology*; D015415:Biomarkers / Q000032:analysis*; D018360:Crystallography, X-Ray; D004797:Enzyme-Linked Immunosorbent Assay; D006031:Glycosylation; D006801:Humans; D009103:Multiple Sclerosis / Q000276:immunology*; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein / Q000138:chemical synthesis* / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D063308:Myelin-Oligodendrocyte Glycoprotein
D000906:Antibodies; D015415:Biomarkers; C571326:MOG protein, human; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein